Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment. (Q34545405)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment. |
scientific article |
Statements
Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment (English)
Y Wang
V Balan
V Hogan
18 November 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference